You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed or Refractory Acute Lymphoblastic Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

T-Cell Acute Lymphocytic Leukemia Trial in Langfang (CD7 CAR-T)

Recruiting
  • T-Cell Acute Lymphocytic Leukemia
  • CD7 CAR-T
  • Langfang, Hebei, China
    Hebei Yanda Hospital
Jun 26, 2023

Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)

Recruiting
  • Acute T-lymphoblastic Leukemia
  • Acute T-lymphoblastic Lymphoma
  • CAR-T Cell Infusion
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

Recruiting
  • B-Cell Non Hodgkin Lymphoma
  • B-Cell Acute Lymphoblastic Leukemia
  • anti-CD19 CAR T-cells
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023

PET-CT Imaging in Relapsed/Refractory Acute Leukemias

Not yet recruiting
  • B Cell
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 4, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • HY004
    • +2 more
    • (no location specified)
    Aug 18, 2023

    T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

    Terminated
    • T-Acute Lymphoblastic Leukemia
    • Adult T Lymphoblastic Lymphoma
    • Saint Louis, Missouri
    • +1 more
    Jan 18, 2023

    Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

    Recruiting
    • Lymphoblastic Lymphoma
    • +2 more
    • BEAM-201
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jun 2, 2023

    Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

    Not yet recruiting
    • Refractory B-cell Acute Lymphoblastic Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • (no location specified)
    Oct 10, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia/Lymphoma
    • Senl-T7
    • Beijing, Hebei, China
      Hebei yanda Hospital
    Nov 22, 2022

    Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

    Not yet recruiting
    • Leukemia, Acute Lymphoblastic
    • Lymphoma, Non-Hodgkin
    • CART-19
    • Ribeirao Preto, Sao Paulo, Brazil
      Ribeirao Preto School of Medicine, University of Sao Paulo
    Oct 23, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • inotuzumab ozogamicin
    • (no location specified)
    Jan 6, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 22, 2023

    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 20, 2023

    Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Miami (Pevonedistat, Vincristine,

    Completed
    • Refractory Acute Lymphoblastic Leukemia
    • Relapsed Acute Lymphoblastic Leukemia
    • Miami, Florida
      University of Miami
    Oct 19, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +4 more
    • Utrecht, Netherlands
      Princess Máxima Center for Pediatric Oncology
    Feb 16, 2023

    Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed

    Recruiting
    • Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Autologous CAR19 T lymphocytes
    • Prague, Czechia
      Institute of Hematology and Blood Transfusion, Czech Republic
    Aug 3, 2022

    Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

    Recruiting
    • Lymphoblastic Leukemia
    • +5 more
    • Anti-CD19 CAR T-cells
    • Singapore, Singapore
    • +1 more
    Dec 4, 2022

    B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Unspecified Trial in Guangzhou, Guanzhou (CD19 CAR T-Cell(CAT19T2))

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-Cell Lymphoma, Unspecified
    • CD19 CAR T-Cell(CAT19T2)
    • Guangzhou, Guangdong, China
    • +1 more
    Nov 4, 2022